Home » Stocks » BIOLASE, Inc.

BIOLASE, Inc. (BIOL)

Stock Price: $0.410 USD -0.010 (-2.38%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed
After-hours: $0.413 +0.003 (0.73%) Aug 4, 7:58 PM

Stock Price Chart

Key Info

Market Cap 20.64M
Revenue (ttm) 32.26M
Net Income (ttm) -18.97M
Shares Out 50.34M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $0.410
Previous Close $0.420
Change ($) -0.010
Change (%) -2.38%
Day's Open 0.416
Day's Range 0.408 - 0.425
Day's Volume 5,359,249
52-Week Range 0.211 - 1.650

More Stats

Market Cap 20.64M
Enterprise Value 32.38M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 50.34M
Float 24.85M
EPS (basic) -0.73
EPS (diluted) -0.74
FCF / Share -0.38
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 713,329
Short Ratio 0.61
Short % of Float 13.89%
Beta 2.07
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.64
PB Ratio 36.64
Revenue 32.26M
Operating Income -16.62M
Net Income -18.97M
Free Cash Flow -12.05M
Net Cash -11.74M
Net Cash / Share -0.23
Gross Margin 44.30%
Operating Margin -51.52%
Profit Margin -58.80%
FCF Margin -37.37%
ROA -35.99%
ROE -623.51%
ROIC -98.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$2.38*
(480.49% upside)
Low
1.65
Current: $0.410
High
3.50
Target: 2.38
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue37.8046.1646.9351.8148.4847.6656.4357.3648.8626.23
Revenue Growth-18.1%-1.64%-9.43%6.88%1.72%-15.55%-1.61%17.39%86.3%-
Gross Profit14.2916.9015.1320.3115.9518.1721.5326.4821.328.83
Operating Income-15.62-20.89-18.04-14.96-19.92-17.94-11.00-2.53-4.00-11.50
Net Income-17.86-21.52-16.85-15.37-20.28-18.93-11.48-3.06-4.49-12.02
Shares Outstanding23.2020.5914.7512.1311.648.456.556.436.125.36
Earnings Per Share-0.77-1.05-1.41-1.45-1.75-2.25-1.75-0.50-0.75-2.26
Operating Cash Flow-12.75-14.15-18.41-10.60-17.77-16.20-9.30-1.66-13.32-3.81
Capital Expenditures-0.21-0.52-0.75-1.41-1.78-0.20-0.68-0.68-0.43-0.24
Free Cash Flow-12.95-14.67-19.16-12.01-19.55-16.40-9.97-2.35-13.75-4.05
Cash & Equivalents6.108.3611.909.1811.9031.561.442.543.311.69
Total Debt13.4710.84--0.16-4.631.64-2.62
Net Cash / Debt-7.37-2.4811.909.1811.7431.56-3.190.913.31-0.93
Assets31.8538.5242.9841.9442.2559.4031.0431.9729.8118.15
Liabilities27.5127.4313.7219.8817.3317.3522.5620.1817.2421.19
Book Value0.3811.0929.2622.0724.9342.068.4811.7912.57-3.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BIOLASE, Inc.
Country United States
Employees 150
CEO Todd A. Norbe

Stock Information

Ticker Symbol BIOL
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: BIOL
IPO Date November 13, 1992

Description

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.